In the context of PD, the dysregulated activation of TP53 has been implicated in promoting neuronal apoptosis and oxidative stress, which in turn exacerbates the neurodegenerative processes (Szybinska and Lesniak, 2017; Wolfrum et al., 2022). This evidence concerns the gene TP53 and Parkinson disease.